Table 1. Demographic and clinical characteristics of 72 patients undergoing hepatic resection as first treatment.
Patient characteristics | Study group (n = 72) | |
---|---|---|
Female sex, n (%) | 35 | 49.3 |
Age, median (range) | 63 | 29–80 |
Cardiac comorbidity, n (%) | 19 | 26.4 |
Pulmonary comorbidity, n (%) | 6 | 8.3 |
Diabetes, n (%) | 15 | 20.8 |
Cirrhosis, n (%) | 23 | 31.9 |
Chronic kidney disease, n (%) | 4 | 5.6 |
Tumour stage, n (%) | ||
T1 | 29 | 41.1 |
T2 | 26 | 37.1 |
T3 | 9 | 12.9 |
T4 | 6 | 8.6 |
Lymph node involvement | 25 | 34.7 |
Bilobar disease, n (%) | 19 | 26.4 |
Diameter of largest lesion, mm, median (range) | 60 | 16–200 |
Number of lesions, median (range) | 1 | 1–4 |
Major hepatectomy, n (%) | 61 | 87.1 |
Type of resection, n (%) | ||
Anatomical | 56 | 80.0 |
Non-anatomical | 6 | 8.6 |
Combined resection | 8 | 11.4 |
Type of anatomical resection, n (%) | ||
Right hepatectomy | 13 | 19.7 |
Left hepatectomy | 12 | 18.2 |
Extended right hepatectomy | 22 | 33.3 |
Extended left hepatectomy | 12 | 18.2 |
Left lateral sectorectomy | 4 | 6.1 |
Segmentectomy | 1 | 1.5 |
Bisegmentectomy | 1 | 1.5 |
ALPPS | 1 | 1.5 |
Laparoscopic approach, n (%) | 5 | 7.1 |
R0, n (%) | 64 | 88.9 |
mm millimetre, ALPPS Associating Liver Partition with Portal vein ligation for Staged hepatectomy